{"id":306106,"date":"2026-10-14T09:06:29","date_gmt":"2026-10-14T03:36:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=306106"},"modified":"2026-10-14T09:06:29","modified_gmt":"2026-10-14T03:36:29","slug":"medicamen-biotech-vs-gennex-laboratories-vs-qms-medical","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/","title":{"rendered":"Medicamen Biotech vs Gennex Laboratories vs QMS Medical: Which Stock Should You Track"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Medicamen Biotech PE 41.70, mkt cap Rs 419 crore. Gennex Laboratories PE 11.49, mkt cap Rs 237 crore. QMS Medical Allied Services PE 29.57, mkt cap Rs 372 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services is a side-by-side comparison of three companies from the pharma and healthcare space. On this comparison, Medicamen Biotech carries a market capitalisation of about Rs 419 crore, against Rs 237 crore for Gennex Laboratories and Rs 372 crore for QMS Medical Allied Services, with return on equity of 3.50%, 8.29% and 9.67% respectively. Each company&#8217;s numbers are presented here without a declared preference, since the right stock depends on an investor&#8217;s own criteria.<\/p>\n<\/div>\n<p>Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services starts with the core numbers most investors compare within the pharma and healthcare segment: market capitalisation, valuation multiples, profitability, dividend yield and the latest quarterly results. Figures below are sourced as of October 2026 and will shift with daily price moves.<\/p>\n<p>All three names sit in the pharma and healthcare bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses. The sections below cover the company profiles, a valuation table, the latest quarter and a five-quarter trend for revenue and net profit.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services_Company_Overview\" title=\"Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services: Company Overview\">Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services: Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#Medicamen_Biotech_vs_Gennex_Laboratories_vs_QMS_Medical_Allied_Services_Valuation_and_Profitability_Snapshot\" title=\"Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Valuation and Profitability Snapshot\">Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Valuation and Profitability Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#Medicamen_Biotech_vs_Gennex_Laboratories_vs_QMS_Medical_Allied_Services_Latest_Quarterly_Results\" title=\"Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Latest Quarterly Results\">Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Latest Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#Medicamen_Biotech_vs_Gennex_Laboratories_vs_QMS_Medical_Allied_Services_Five-Quarter_Revenue_and_Net_Profit_Trend\" title=\"Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Five-Quarter Revenue and Net Profit Trend\">Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Five-Quarter Revenue and Net Profit Trend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#What_Should_Investors_Look_at_Beyond_These_Numbers\" title=\"What Should Investors Look at Beyond These Numbers?\">What Should Investors Look at Beyond These Numbers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#FAQs_on_Medicamen_Biotech_vs_Gennex_Laboratories_vs_QMS_Medical_Allied_Services\" title=\"FAQs on Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services\">FAQs on Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#What_is_the_market_cap_difference_between_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\" title=\"What is the market cap difference between Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\">What is the market cap difference between Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#What_are_the_PE_and_PB_ratios_of_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\" title=\"What are the PE and PB ratios of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\">What are the PE and PB ratios of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#Which_of_the_three_has_the_highest_ROE\" title=\"Which of the three has the highest ROE?\">Which of the three has the highest ROE?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#Which_of_these_three_stocks_pays_the_highest_dividend_yield\" title=\"Which of these three stocks pays the highest dividend yield?\">Which of these three stocks pays the highest dividend yield?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#What_is_the_debt_to_equity_ratio_for_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\" title=\"What is the debt to equity ratio for Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\">What is the debt to equity ratio for Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#What_were_the_latest_quarterly_revenue_and_net_profit_of_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\" title=\"What were the latest quarterly revenue and net profit of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\">What were the latest quarterly revenue and net profit of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical\/#Does_this_comparison_recommend_one_of_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\" title=\"Does this comparison recommend one of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\">Does this comparison recommend one of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services_Company_Overview\"><\/span><strong>Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services: Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Medicamen Biotech<\/strong> is a listed Indian company in the pharma and healthcare space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 419 crore, a return on equity of 3.50% and a book value of Rs 196.82 per share. Its quarterly revenue moved from Rs 43.51 crore in June 2025 to Rs 48.76 crore in June 2026, a change of +12.1%.<\/p>\n<p><strong>Gennex Laboratories<\/strong> is a listed Indian company in the pharma and healthcare space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 237 crore, a return on equity of 8.29% and a book value of Rs 9.16 per share. Its quarterly revenue moved from Rs 36.46 crore in June 2025 to Rs 41.85 crore in June 2026, a change of +14.8%.<\/p>\n<p><strong>QMS Medical Allied Services<\/strong> is a listed Indian company in the pharma and healthcare space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 372 crore, a return on equity of 9.67% and a book value of Rs 53.88 per share. Its quarterly revenue moved from Rs 46.82 crore in June 2025 to Rs 57.29 crore in June 2026, a change of +22.4%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Medicamen_Biotech_vs_Gennex_Laboratories_vs_QMS_Medical_Allied_Services_Valuation_and_Profitability_Snapshot\"><\/span><strong>Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Valuation and Profitability Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/medicameq\/medicamen-biotech-ltd-share-price-today\">Medicamen Biotech<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/genne\/gennex-laboratories-ltd-share-price-today\">Gennex Laboratories<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/qmsmedi\/qms-medical-allied-services-ltd-share-price-today\">QMS Medical Allied Services<\/a><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Market Cap (approx.)<\/td>\n<td>Rs 419 crore<\/td>\n<td>Rs 237 crore<\/td>\n<td>Rs 372 crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio (TTM)<\/td>\n<td>41.70<\/td>\n<td>11.49<\/td>\n<td>29.57<\/td>\n<\/tr>\n<tr>\n<td>PB Ratio<\/td>\n<td>1.57<\/td>\n<td>1.07<\/td>\n<td>3.57<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity (ROE)<\/td>\n<td>3.50%<\/td>\n<td>8.29%<\/td>\n<td>9.67%<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM, Rs)<\/td>\n<td>7.40<\/td>\n<td>0.85<\/td>\n<td>6.51<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>0.32%<\/td>\n<td>0.00%<\/td>\n<td>2.60%<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.17<\/td>\n<td>0.36<\/td>\n<td>0.65<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share (Rs)<\/td>\n<td>196.82<\/td>\n<td>9.16<\/td>\n<td>53.88<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Data<\/strong><\/a><\/p>\n<p>On valuation, Medicamen Biotech trades at a PE of 41.70 and a PB of 1.57, Gennex Laboratories at a PE of 11.49 and a PB of 1.07, while QMS Medical Allied Services trades at a PE of 29.57 and a PB of 3.57. On return on equity, the three post 3.50%, 8.29% and 9.67% respectively, and on dividend yield they stand at 0.32%, 0.00% and 2.60%. Medicamen Biotech has the highest market capitalisation of the three at Rs 419 crore, while Gennex Laboratories has the lowest at Rs 237 crore. Medicamen Biotech has the highest PE ratio of the three at 41.70, while Gennex Laboratories has the lowest at 11.49. QMS Medical Allied Services has the highest return on equity of the three at 9.67%, while Medicamen Biotech has the lowest at 3.50%. QMS Medical Allied Services has the highest debt to equity ratio of the three at 0.65, while Medicamen Biotech has the lowest at 0.17. Debt to equity is 0.17, 0.36 and 0.65 for the three respectively.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Medicamen_Biotech_vs_Gennex_Laboratories_vs_QMS_Medical_Allied_Services_Latest_Quarterly_Results\"><\/span><strong>Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Latest Quarterly Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Company<\/th>\n<th>Latest Quarter Revenue<\/th>\n<th>Latest Quarter Net Profit<\/th>\n<th>YoY Change (Revenue)<\/th>\n<th>QoQ Change (Revenue)<\/th>\n<th>YoY Change (Net Profit)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Medicamen Biotech<\/td>\n<td>Rs 48.76 crore<\/td>\n<td>Rs 1.85 crore<\/td>\n<td>+12.1%<\/td>\n<td>-21.8%<\/td>\n<td>+15.6%<\/td>\n<\/tr>\n<tr>\n<td>Gennex Laboratories<\/td>\n<td>Rs 41.85 crore<\/td>\n<td>Rs 4.67 crore<\/td>\n<td>+14.8%<\/td>\n<td>-32.8%<\/td>\n<td>-7.0%<\/td>\n<\/tr>\n<tr>\n<td>QMS Medical Allied Services<\/td>\n<td>Rs 57.29 crore<\/td>\n<td>Rs 3.96 crore<\/td>\n<td>+22.4%<\/td>\n<td>+28.3%<\/td>\n<td>+25.3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter. A percentage change in net profit is shown as NA where the comparison quarter was a loss or the latest quarter is a loss, since the percentage is not meaningful in that case.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Medicamen_Biotech_vs_Gennex_Laboratories_vs_QMS_Medical_Allied_Services_Five-Quarter_Revenue_and_Net_Profit_Trend\"><\/span><strong>Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services: Five-Quarter Revenue and Net Profit Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The five-quarter view below shows how revenue and net profit moved from June 2025 to June 2026 for each company in Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services, which helps separate a one-quarter move from a steadier pattern.<\/p>\n<p><strong>Quarterly revenue (Rs crore)<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Medicamen Biotech<\/th>\n<th>Gennex Laboratories<\/th>\n<th>QMS Medical Allied Services<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>June 2025<\/td>\n<td>Rs 43.51 crore<\/td>\n<td>Rs 36.46 crore<\/td>\n<td>Rs 46.82 crore<\/td>\n<\/tr>\n<tr>\n<td>September 2025<\/td>\n<td>Rs 47.54 crore<\/td>\n<td>Rs 39.30 crore<\/td>\n<td>Rs 44.92 crore<\/td>\n<\/tr>\n<tr>\n<td>December 2025<\/td>\n<td>Rs 47.44 crore<\/td>\n<td>Rs 45.55 crore<\/td>\n<td>Rs 37.56 crore<\/td>\n<\/tr>\n<tr>\n<td>March 2026<\/td>\n<td>Rs 62.39 crore<\/td>\n<td>Rs 62.28 crore<\/td>\n<td>Rs 44.64 crore<\/td>\n<\/tr>\n<tr>\n<td>June 2026<\/td>\n<td>Rs 48.76 crore<\/td>\n<td>Rs 41.85 crore<\/td>\n<td>Rs 57.29 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Quarterly net profit (Rs crore)<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Medicamen Biotech<\/th>\n<th>Gennex Laboratories<\/th>\n<th>QMS Medical Allied Services<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>June 2025<\/td>\n<td>Rs 1.60 crore<\/td>\n<td>Rs 5.02 crore<\/td>\n<td>Rs 3.16 crore<\/td>\n<\/tr>\n<tr>\n<td>September 2025<\/td>\n<td>Rs 2.11 crore<\/td>\n<td>Rs 5.51 crore<\/td>\n<td>Rs 3.58 crore<\/td>\n<\/tr>\n<tr>\n<td>December 2025<\/td>\n<td>Rs 1.63 crore<\/td>\n<td>Rs 5.99 crore<\/td>\n<td>Rs 3.17 crore<\/td>\n<\/tr>\n<tr>\n<td>March 2026<\/td>\n<td>Rs 4.45 crore<\/td>\n<td>Rs 4.46 crore<\/td>\n<td>Rs 1.88 crore<\/td>\n<\/tr>\n<tr>\n<td>June 2026<\/td>\n<td>Rs 1.85 crore<\/td>\n<td>Rs 4.67 crore<\/td>\n<td>Rs 3.96 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Medicamen Biotech reported revenue of Rs 43.51 crore in June 2025 and Rs 48.76 crore in June 2026, a change of +12.1% across the period. Its highest quarterly revenue in this window was Rs 62.39 crore in March 2026. Net profit stood at Rs 1.85 crore in June 2026, which is a net profit margin of 3.79%.<\/p>\n<p>Gennex Laboratories reported revenue of Rs 36.46 crore in June 2025 and Rs 41.85 crore in June 2026, a change of +14.8% across the period. Its highest quarterly revenue in this window was Rs 62.28 crore in March 2026. Net profit stood at Rs 4.67 crore in June 2026, which is a net profit margin of 11.16%.<\/p>\n<p>QMS Medical Allied Services reported revenue of Rs 46.82 crore in June 2025 and Rs 57.29 crore in June 2026, a change of +22.4% across the period. Its highest quarterly revenue in this window was Rs 57.29 crore in June 2026. Net profit stood at Rs 3.96 crore in June 2026, which is a net profit margin of 6.91%.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Should_Investors_Look_at_Beyond_These_Numbers\"><\/span><strong>What Should Investors Look at Beyond These Numbers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Beyond the metrics above, investors comparing these three pharma and healthcare names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and factors specific to the segment such as regulatory approvals, order flow, raw material costs and the small revenue base that makes quarterly results swing. A single-quarter snapshot can shift quickly, and smaller companies in particular can show wide swings from one quarter to the next.<\/p>\n<p>It also helps to read the latest quarterly filings and investor presentations of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services directly, since the figures here come from standardised data and do not capture company-specific context such as one-time items, order timing or promoter actions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services highlights how differently three companies in the same pharma and healthcare segment can look across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information as of October 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Medicamen_Biotech_vs_Gennex_Laboratories_vs_QMS_Medical_Allied_Services\"><\/span><strong>FAQs on Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_difference_between_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\"><\/span><strong>What is the market cap difference between Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of October 2026, Medicamen Biotech has a market cap of approximately Rs 419 crore, Gennex Laboratories is at approximately Rs 237 crore, and QMS Medical Allied Services is at approximately Rs 372 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_PE_and_PB_ratios_of_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\"><\/span><strong>What are the PE and PB ratios of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of October 2026, the PE ratios stand at 41.70, 11.49 and 29.57 respectively, and the price to book ratios stand at 1.57, 1.07 and 3.57 respectively.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_the_three_has_the_highest_ROE\"><\/span><strong>Which of the three has the highest ROE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services post ROE of 3.50%, 8.29% and 9.67% respectively as of October 2026. QMS Medical Allied Services has the highest return on equity of the three at 9.67%, while Medicamen Biotech has the lowest at 3.50%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_three_stocks_pays_the_highest_dividend_yield\"><\/span><strong>Which of these three stocks pays the highest dividend yield?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services carry dividend yields of 0.32%, 0.00% and 2.60% respectively.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_debt_to_equity_ratio_for_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\"><\/span><strong>What is the debt to equity ratio for Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Medicamen Biotech carries a debt to equity of 0.17, Gennex Laboratories of 0.36, and QMS Medical Allied Services of 0.65.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_latest_quarterly_revenue_and_net_profit_of_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\"><\/span><strong>What were the latest quarterly revenue and net profit of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> For Q1 FY27 (quarter ended June 2026), Medicamen Biotech reported revenue of Rs 48.76 crore and net profit of Rs 1.85 crore, Gennex Laboratories reported revenue of Rs 41.85 crore and net profit of Rs 4.67 crore, and QMS Medical Allied Services reported revenue of Rs 57.29 crore and net profit of Rs 3.96 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_this_comparison_recommend_one_of_Medicamen_Biotech_Gennex_Laboratories_and_QMS_Medical_Allied_Services\"><\/span><strong>Does this comparison recommend one of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This comparison does not declare one stock ahead of another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor&#8217;s own criteria and research.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the market cap difference between Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of October 2026, Medicamen Biotech has a market cap of approximately Rs 419 crore, Gennex Laboratories is at approximately Rs 237 crore, and QMS Medical Allied Services is at approximately Rs 372 crore.\"}},{\"@type\":\"Question\",\"name\":\"What are the PE and PB ratios of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of October 2026, the PE ratios stand at 41.70, 11.49 and 29.57 respectively, and the price to book ratios stand at 1.57, 1.07 and 3.57 respectively.\"}},{\"@type\":\"Question\",\"name\":\"Which of the three has the highest ROE?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services post ROE of 3.50%, 8.29% and 9.67% respectively as of October 2026. QMS Medical Allied Services has the highest return on equity of the three at 9.67%, while Medicamen Biotech has the lowest at 3.50%.\"}},{\"@type\":\"Question\",\"name\":\"Which of these three stocks pays the highest dividend yield?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services carry dividend yields of 0.32%, 0.00% and 2.60% respectively.\"}},{\"@type\":\"Question\",\"name\":\"What is the debt to equity ratio for Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicamen Biotech carries a debt to equity of 0.17, Gennex Laboratories of 0.36, and QMS Medical Allied Services of 0.65.\"}},{\"@type\":\"Question\",\"name\":\"What were the latest quarterly revenue and net profit of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"For Q1 FY27 (quarter ended June 2026), Medicamen Biotech reported revenue of Rs 48.76 crore and net profit of Rs 1.85 crore, Gennex Laboratories reported revenue of Rs 41.85 crore and net profit of Rs 4.67 crore, and QMS Medical Allied Services reported revenue of Rs 57.29 crore and net profit of Rs 3.96 crore.\"}},{\"@type\":\"Question\",\"name\":\"Does this comparison recommend one of Medicamen Biotech, Gennex Laboratories and QMS Medical Allied Services?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This comparison does not declare one stock ahead of another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services compared on market cap, PE, ROE and quarterly results, as of October 2026.<\/p>\n","protected":false},"author":38,"featured_media":306105,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[11016,1019],"class_list":["post-306106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-pharma-and-healthcare","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["306105"],"rank_math_title":["Medicamen Biotech vs Gennex Laboratories vs QMS Medical"],"rank_math_description":["Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services compared on market cap, PE, ROE and quarterly results, as of October 2026."],"rank_math_focus_keyword":["Medicamen Biotech vs Gennex Laboratories vs QMS Medical Allied Services"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/medicamen-biotech-vs-gennex-laboratories-vs-qms-medical-which-stock-should-you.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/306106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=306106"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/306106\/revisions"}],"predecessor-version":[{"id":306107,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/306106\/revisions\/306107"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/306105"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=306106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=306106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=306106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}